| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |